Mark A. Rydell
Keine laufenden Positionen mehr
Karriereverlauf von Mark A. Rydell
Ehemalige bekannte Positionen von Mark A. Rydell
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Everest Medical Corp.
 Everest Medical Corp. Medical SpecialtiesHealth Technology Part of Olympus Corp., Everest Medical Corp. is a designer, manufacturer, and seller of laparoscopic surgical products. The company is based in Minneapolis, MN. Everest Medical was acquired by Gyrus Group Ltd. on April 14, 2000 for $37.20 million. | Corporate Officer/Principal | 01.01.1988 | 01.01.1993 |
| Angiomedics, Inc. | Corporate Officer/Principal | - | - |
Advanced Bio-Surfaces, Inc.
 Advanced Bio-Surfaces, Inc. Medical DistributorsDistribution Services Advanced Bio-Surfaces, Inc. manufactures medical devices. Its products include orthopedic implant and applications, biocompatible polymers, and biomaterials. Advanced Bio-Surfaces was founded by Jeffrey C. Felt in 1994 and is headquartered in Minnetonka, MN. | Corporate Officer/Principal | 01.01.1997 | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 3 |
Sektoral
| Distribution Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Advanced Bio-Surfaces, Inc.
Advanced Bio-Surfaces, Inc. Medical DistributorsDistribution Services Advanced Bio-Surfaces, Inc. manufactures medical devices. Its products include orthopedic implant and applications, biocompatible polymers, and biomaterials. Advanced Bio-Surfaces was founded by Jeffrey C. Felt in 1994 and is headquartered in Minnetonka, MN. | Distribution Services |
| Angiomedics, Inc. | |
Everest Medical Corp.
Everest Medical Corp. Medical SpecialtiesHealth Technology Part of Olympus Corp., Everest Medical Corp. is a designer, manufacturer, and seller of laparoscopic surgical products. The company is based in Minneapolis, MN. Everest Medical was acquired by Gyrus Group Ltd. on April 14, 2000 for $37.20 million. | Health Technology |
- Börse
- Insiders
- Mark A. Rydell
- Erfahrung
